Assessment of cytomegalovirus and cell-mediated immunity for predicting outcomes in non-HIV-infected patients with Pneumocystis jirovecii pneumonia.

about

Assessment of cytomegalovirus and cell-mediated immunity for predicting outcomes in non-HIV-infected patients with Pneumocystis jirovecii pneumonia.

Item

http://www.wikidata.org/entity/Q38660319

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Assessment of cytomegalovirus ...... umocystis jirovecii pneumonia.

@en

type

Item

label

Assessment of cytomegalovirus ...... umocystis jirovecii pneumonia.

@en

prefLabel

Assessment of cytomegalovirus ...... umocystis jirovecii pneumonia.

@en

P1476

Assessment of cytomegalovirus ...... umocystis jirovecii pneumonia.

@en

P2093

Heungsup Sung

http://www.w3.org/2001/XMLSchema#string

Hyun-Jung Lee

http://www.w3.org/2001/XMLSchema#string

Jun Hee Woo

http://www.w3.org/2001/XMLSchema#string

Sang-Ho Choi

http://www.w3.org/2001/XMLSchema#string

Sang-Oh Lee

http://www.w3.org/2001/XMLSchema#string

Se Yoon Park

http://www.w3.org/2001/XMLSchema#string

Sun-Mi Kim

http://www.w3.org/2001/XMLSchema#string

Sung-Han Kim

http://www.w3.org/2001/XMLSchema#string

Taeeun Kim

http://www.w3.org/2001/XMLSchema#string

Yang Soo Kim

http://www.w3.org/2001/XMLSchema#string

P2860

State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician

Prognostic markers of short-term mortality in AIDS-associated Pneumocystis carinii pneumonia.

Cytomegalovirus pneumonia.

Principles and practical application of the receiver-operating characteristic analysis for diagnostic tests.

Opportunistic infections in patients with and patients without Acquired Immunodeficiency Syndrome.

A Prospective Monitoring Study of Cytomegalovirus Infection in Non-Immunosuppressed Critical Heart Surgery Patients

Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials.

Cytomegalovirus infections in solid organ transplantation: a review.

Cytomegalovirus reactivation in critically ill immunocompetent patients.

CMV in critically ill patients: pathogen or bystander?

P304

e7243

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/MD.0000000000007243

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28746178

http://www.w3.org/2001/XMLSchema#string

P921

Bruschtfiewer

Cytomegalovirus

P932

5627804

http://www.w3.org/2001/XMLSchema#string